Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group (Q44158544)
Jump to navigation
Jump to search
scientific article published on 20 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group |
scientific article published on 20 July 2009 |
Statements
1 reference
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group (English)
1 reference
Ichiro Tsukimoto
1 reference
Akio Tawa
1 reference
Keizo Horibe
1 reference
Ken Tabuchi
1 reference
Hisato Kigasawa
1 reference
Masahiro Tsuchida
1 reference
Hiromasa Yabe
1 reference
Hideki Nakayama
1 reference
Kazuko Kudo
1 reference
Ryoji Kobayashi
1 reference
Kazuko Hamamoto
1 reference
Masue Imaizumi
1 reference
Akira Morimoto
1 reference
Shigeru Tsuchiya
1 reference
Ryoji Hanada
1 reference
20 July 2009
1 reference
1 reference
Identifiers
1 reference